Search Page

1

Cite

Share

Non-pharmacologic management of attention-deficit/hyperactivity disorder in children and adolescents: a review.

Shrestha M, Lautenschleger J, Soares N. Shrestha M, et al. Transl Pediatr. 2020 Feb;9(Suppl 1):S114-S124. doi: 10.21037/tp.2019.10.01. Transl Pediatr. 2020. PMID: 32206589 Free PMC article. Review.

Cite

Share

2

Cite

Share

Charting the cis-regulome of activated B cells by coupling structural and functional genomics.

Chaudhri VK, Dienger-Stambaugh K, Wu Z, Shrestha M, Singh H. Chaudhri VK, et al. Among authors: shrestha m. Nat Immunol. 2020 Feb;21(2):210-220. doi: 10.1038/s41590-019-0565-0. Epub 2019 Dec 23. Nat Immunol. 2020. PMID: 31873292

Cite

Share

3

Cite

Share

A FOXO1-induced oncogenic network defines the AML1-ETO preleukemic program.

Lin S, Ptasinska A, Chen X, Shrestha M, Assi SA, Chin PS, Imperato MR, Aronow BJ, Zhang J, Weirauch MT, Bonifer C, Mulloy JC. Lin S, et al. Among authors: shrestha m. Blood. 2017 Sep 7;130(10):1213-1222. doi: 10.1182/blood-2016-11-750976. Epub 2017 Jul 14. Blood. 2017. PMID: 28710059 Free PMC article.

Cite

Share

4

Cite

Share

Acute pancreatitis with normal amylase and lipase--an ED dilemma.

Singh A, Shrestha M, Anand C. Singh A, et al. Among authors: shrestha m. Am J Emerg Med. 2016 May;34(5):940.e5-7. doi: 10.1016/j.ajem.2015.10.026. Epub 2015 Oct 23. Am J Emerg Med. 2016. PMID: 26521195 No abstract available.

Cite

Share

5

Cite

Share

MAPK8-mediated stabilization of SP1 is essential for RUNX1-RUNX1T1 - driven leukaemia.

Maiques-Diaz A, Hernando M, Sánchez-López A, Rio-Machin A, Shrestha M, Mulloy JC, Cigudosa JC, Alvarez S. Maiques-Diaz A, et al. Among authors: shrestha m. Br J Haematol. 2016 Mar;172(5):807-10. doi: 10.1111/bjh.13536. Epub 2015 Jun 8. Br J Haematol. 2016. PMID: 26058961 No abstract available.

Cite

Share

6

Cite

Share

Supraphysiologic levels of the AML1-ETO isoform AE9a are essential for transformation.

Link KA, Lin S, Shrestha M, Bowman M, Wunderlich M, Bloomfield CD, Huang G, Mulloy JC. Link KA, et al. Among authors: shrestha m. Proc Natl Acad Sci U S A. 2016 Aug 9;113(32):9075-80. doi: 10.1073/pnas.1524225113. Epub 2016 Jul 25. Proc Natl Acad Sci U S A. 2016. PMID: 27457952 Free PMC article.

Cite

Share

7

Cite

Share

The full transforming capacity of MLL-Af4 is interlinked with lymphoid lineage commitment.

Lin S, Luo RT, Shrestha M, Thirman MJ, Mulloy JC. Lin S, et al. Among authors: shrestha m. Blood. 2017 Aug 17;130(7):903-907. doi: 10.1182/blood-2017-04-777185. Epub 2017 Jun 21. Blood. 2017. PMID: 28637661 Free PMC article.

Cite

Share

8

Cite

Share

Early alterations in stem-like/resident T cells, innate and myeloid cells in the bone marrow in preneoplastic gammopathy.

Bailur JK, McCachren SS, Doxie DB, Shrestha M, Pendleton K, Nooka AK, Neparidze N, Parker TL, Bar N, Kaufman JL, Hofmeister CC, Boise LH, Lonial S, Kemp ML, Dhodapkar KM, Dhodapkar MV. Bailur JK, et al. Among authors: shrestha m. JCI Insight. 2019 Apr 23;5(11):e127807. doi: 10.1172/jci.insight.127807. JCI Insight. 2019. PMID: 31013254 Free PMC article.

Cite

Share

9

Cite

Share

AML cells are differentially sensitive to chemotherapy treatment in a human xenograft model.

Wunderlich M, Mizukawa B, Chou FS, Sexton C, Shrestha M, Saunthararajah Y, Mulloy JC. Wunderlich M, et al. Among authors: shrestha m. Blood. 2013 Mar 21;121(12):e90-7. doi: 10.1182/blood-2012-10-464677. Epub 2013 Jan 24. Blood. 2013. PMID: 23349390 Free PMC article.

Cite

Share

10

Cite

Share

The thrombopoietin/MPL/Bcl-xL pathway is essential for survival and self-renewal in human preleukemia induced by AML1-ETO.

Chou FS, Griesinger A, Wunderlich M, Lin S, Link KA, Shrestha M, Goyama S, Mizukawa B, Shen S, Marcucci G, Mulloy JC. Chou FS, et al. Among authors: shrestha m. Blood. 2012 Jul 26;120(4):709-19. doi: 10.1182/blood-2012-01-403212. Epub 2012 Feb 14. Blood. 2012. PMID: 22337712 Free PMC article.

Cite

Share